Keyword: Massachusetts

Two statehouses are taking the lead on reining in exorbitant drug prices as prescription spending booms. But that fight won’t be easy.

The pharma industry is opening its checkbook to fight state-level bills that could cap drug prices and reveal drugmakers' pricing rationale.

Under the weight of thousands of opioid lawsuits, Purdue may seek bankruptcy protection, Reuters reports.

As federal drug pricing moves have floundered, state officials got busy. But Massachusetts is discovering there's a limit to drug-pricing innovation.

A lawsuit from Massachusetts is the first to target Purdue executives and directors, according to the state's attorney general.

California is starting to see early results from its new drug price transparency law, with red flags raised on two big hikes.

Two workers at the Pharmasol manufacturing facility in Easton, Massachusetts, were injured when an aerosol can exploded and triggered a small fire last week.

California lawmakers are weighing a bill that would cut off most drugmaker payments to physicians, including speaking fees for that staple of pharma marketing, the slideshow over dinner.

Federal Medicaid officials lectured Gilead Sciences and other hep C drugmakers last year on the need to find ways to cut prices on their pricey meds for state Medicaid programs. Now, Massachusetts says it has a deal for rebates from Gilead in exchange for an exclusive on its hep C cure Harvoni. 

Researchers at Case Western University in Cleveland and MIT have combined forces around a new nanoparticle from a plant virus that shrunk tumors in vivo by delivering an unapproved chemo drug, outpacing the more common cisplatin in triple-negative breast cancer.